expression of the static genome and biological activity. As an alternative to hypothesis-driven approaches to protein biomarker discovery, the past 5 years has seen the emergence of untargeted studies using modern high-throughput proteomics technologies. The bottom-up proteomics methodology involves enzymatic digestion of proteins, application of a separations method on the resulting peptides, ionization and isolation of peptides in a mass spectrometer (MS), and often fragmentation of the peptides (tandem MS/MS). To identify a peptide, the mass of each peptide ion is measured before fragmentation, with fragmentation occurring under known mechanisms and yielding spectra that can elucidate the sequence of the peptide.
Identified peptides can then be attributed to proteins using protein sequence databases.
Proteomics studies of periodontitis have featured different biofluids and experimental protocols. Gingival crevicular fluid is most commonly used as a source for biomarkers due to the ability to reflect serum composition and its role as an exudate in periodontal disease. 5 Gingival crevicular fluid samples are often pooled per-patient to produce a more robust protein source that amplifies low-abundance proteins. 6 High-throughput proteomics platforms have been used to study gingival crevicular fluid samples from patients with chronic periodontitis, [7] [8] [9] [10] generalized aggressive periodontitis 11 and maintenance-phase chronic periodontitis. 12, 13 Saliva can act as a surrogate to gingival crevicular fluid, though gingival crevicular fluid only accounts for <10% of the total protein content. 14 Saliva collection is not as technically demanding as gingival crevicular fluid collection. However, the utilization of saliva as a biomarker source in carefully controlled clinical studies is more challenging due to large abundance ranges, the presence of proteases and an extremely complex protein composition that can be affected by environmental or/and psychological stimuli and therefore in the present study gingival crevicular fluid was chosen as the biological fluid for investigation. 4, [15] [16] [17] One-and two-dimensional electrophoresis separations have been utilized with success, but recent studies featured liquid chromatography (LC) separations, typically paired with electrospray ionization, and typically produced an order of magnitude higher number of protein identifications. We refer to recent reviews for a more comprehensive overview.
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The aim of this study was to identify temporal proteomic profiles of chronic periodontitis. Previous studies from our group, defined proteomic profiles of patients with chronic periodontitis versus healthy controls 8 and developed a predictive model based on mixedinteger linear optimization (MILP) for identifying small subsets of diagnostic protein biomarker candidates. 9 The current study observed dynamic changes in 10 patients diagnosed with chronic periodontitis as they undertook a 13-week treatment program. 
| MATERIAL AND ME THODS

| Subject sample collection
Ten patients diagnosed with chronic periodontitis and had not previously received treatment for the disease were selected to participate in this study. All participants were patients of the Department of Preventive Dentistry, Periodontology and Implant Biology, Dental School, Aristotle University, Thessaloniki, Greece. The participants included 5 male subjects (mean age ± SD of 50.2 ± 3.5 years) and 5 age-matched female subjects (mean age ± SD of 47.4 ± 3.4 years). Clinical parameters for participants are presented in Table 1 . All subjects were nonsmokers who were systemically healthy and were not taking medication known to affect periodontal tissues. Subjects who reported antibiotic intake during the previous 6 months and those who were pregnant or lactating women were excluded from the present study. Subjects were diagnosed with chronic periodontitis according to the analytical criteria of the American Academy of Periodontology. 19 Patients were required to meet the thresholds for moderate or advanced chronic periodontitis (presence of proximal attachment loss of ≥5 mm in ≥30% of teeth present 20 ) and were willing to perform oral hygiene as instructed. All subjects signed an informed consent, and the study was conducted the Ethical Committee of the School of Dentistry (protocol no. 237).
| Clinical recordings and treatment procedures
Clinical parameters were assessed at 6 sites of all teeth present in the dentition, and included probing depth, recession, clinical attachment level and bleeding on probing. Recordings were performed by a calibrated examiner (DS) using an automated probe 
| Gingival crevicular fluid samples
One pooled gingival crevicular fluid sample was collected from each participant at each time point. Samples were taken from 4 preselected sites that displayed a baseline probing depth >6 mm and <8 mm as previously described. 8, 9 After isolation of a site with cotton rolls to prevent contamination with saliva, supragingival plaque was fragmentation. Raw MS data were centroided and converted to the mzXML format using the msconvert tool from ProteoWizard toolbox 21 within the Trans-Proteomic Pipeline. 22 All MS/MS spectra were processed using an improved version of the PILOT_PROTEIN protein identification suite [23] [24] [25] [26] using a subset of the Swissprot database derived from the Homo sapiens taxonomy. Search tolerances included a value of 0.1 Da for the precursor ion and 0.5 Da for the fragment ion. Searches were performed using a maximum of 2 missed cleavages and a static cysteine modification of 57 Da due to the iodoacetimide treatment. The false discovery rate for protein identification utilized in this study was 2% and was calculated using a reverse-sequence decoy database. 25 Positive identification of a protein was allowed for one peptide if that particular amino acid sequence could not be associated with another protein in the database and meets a scoring threshold. 25 All other positive protein identifications required at least 2 annotated peptides.
| Statistical analysis for clinical parameters
| Biomarker selection by temporal profiling
Temporal profiling of periodontitis was performed by analyzing per-patient trends and population-based trends. For each patient, any proteins that were detected at baseline, not detected at treatment conclusion and transitioned once between presence and absence over time in the patient's samples, or vice versa (ie, not detected and then detected), were considered to be candidate biomarkers for that patient. For example, a protein that is detected in patient 1 at baseline and at weeks 1 and 5, and not detected in patient 1 at weeks 9 and 13, would be considered a candidate biomarker for patient 1. This will be referred to as the pattern matching test for the detection of patterns consistent with upregulation or downregulation of the protein as the patient undergoes treatment.
Across all patients, the fractions of patients for which a protein p was detected as a function of time, f p (t) was fit to the logistic function by performing logistic regression to find parameters β 0 and β 1 .
The parameters determine the rate of change and direction of the logistic function as it transitions from 0 to 1 or from 1 to 0.
Good candidate biomarkers would be expected in this scenario to transition somewhere between t = 0 and t = 13, and for much of the transition to occur within this time range. Thus, proteins for which |f p (13) − f p (0)| ≥ 0.5 were kept as candidate biomarkers. This will be referred to as the logistic function test for the detection of population-level up-or downregulation of proteins across the samples.
| Biomarker selection by mixed-integer linear optimization
Data from the baseline and the endpoint for each patient was used 
| Cross-validation studies
The 2 temporal biomarker selection filters yielded 4 candidate biomarkers (see Table 2 ), which may be used to assess clinical endpoints for patients with chronic periodontitis. The proteomic profile data for the 4 candidate biomarkers were then evaluated in cross-validation stud- for each partition, and the averages are summarized in Table 3 .
| RE SULTS
Clinical parameters for participants are summarized in Table 1 . All clinical parameters of periodontal disease were significantly different between baseline and 13 weeks after treatment (Wilcoxon signed ranks test, P < .05).
The numbers of proteins or protein groups identified in each sample are shown in Table 4 . When a set of peptides identified in a f p (t) = 1 + exp(β 0 +β 1 t) sample are able to be attributed to more than 1 protein, the proteins are kept together as a protein group and only contribute as 1 identification count in Table 4 . These protein groups remained unbroken even after the per-sample protein inference methods implemented in the PILOT_PROTEIN suite. The specific proteins identified per patient and per sample are given in Table S1 of the Supporting in-
formation. An alternative protein inference algorithm based on principles of parsimony was attempted, which took into account protein identifications across samples. Briefly, over each set of samples per week, protein groups were reduced to only include proteins, which were identified as single proteins (ie, not within a group) elsewhere in the data. This simplified a number of protein groups but did not alter the results, and thus for simplicity was not included. Thus, in the view of the temporal profiling, all proteins belonging to a group were first ungrouped and considered to be present individually, and were then regrouped post-analysis given that they generated the same temporal profile and were always found grouped together in the initial data.
The MILP model utilized only baseline and endpoint data, which was grouped, and the top 5 candidate biomarkers are shown in Table 5 . The model also determined which status, disease or health, each candidate biomarker indicated. The model was solved in less than 2 CPU seconds using GAMS (version 24.3) and the ILOG CPLEX solver.
Four proteins or protein groups displayed strong temporal profiles, and were independently selected by both the pattern matching and logistic function tests. The results of the 2 filters are shown in Table 2 . Interestingly, these 4 proteins were also included in the top 5 selected by the MILP model. The endpoint data (baseline and week 13) involving the 4 candidates of Table 2 were utilized in the crossvalidation studies. Averaged over all 100 training-testing partitions, the testing accuracy was 0.900 and the AUC was 0.930. Owing to the low numbers of testing instances and qualitative nature of the data, the results were highly sensitive to individual samples. Eighty percent of the partitions had a testing accuracy and AUC of 1; it is predicted that larger datasets and more quantitative data would further increase these metrics for the candidate biomarkers.
| D ISCUSS I ON
From the perspective of the current analyses, the strongest candidate biomarker for periodontitis is azurocidin, which was upregulated at baseline and downregulated as the treatment course proceeded. No azurocidin was detected in any patient at week 13 of the treatment course. Azurocidin is a neutrophil granule-derived protein known for its antimicrobial activity, particularly against gram-negative bacteria. 32, 33 It is present in the azurophilic granules of polymorphonuclear neutrophils along with myeloperoxidase, cathepsin-G, elastase, lysozyme and other antimicrobial compounds. Owing to its cationic nature, azurocidin is able to disrupt the structure of the outer membrane of gram-negative bacteria via binding with lipopolysaccharides. 33 This is particularly relevant to periodontitis, as all members of the "red complex" group of bacteria, identified by Socransky and coworkers as highly associated with periodontal disease, are gramnegative. 34 Azurocidin has been previously identified in gingival crevicular fluid samples but not in saliva collected from patients with chronic periodontitis, using both LC-MS/MS and enzyme-linked immunosorbent assay analyses.
7,35
The profile of the bacteriolytic protein lysozyme C was similar to that of azurocidin. No lysozyme C was detected in any patient at week 13 of the treatment course. Lysozyme is a cationic protein component of gingival crevicular fluid and saliva with antimicrobial activity against both gram-positive and gram-negative bacteria via depriving microorganisms of iron. [36] [37] [38] It has been detected via highthroughput proteomics studies in gingival crevicular fluid samples obtained from patients with chronic periodontitis and gingivitis. 6, 9 No changes in gingival crevicular fluid levels of lysozyme have been reported 2 weeks following surgical periodontal treatment. 39 Though the periodontal treatments are not comparable, in the present study, detection levels of lysozyme C were still high (80% The only strong temporal profile that was upregulated as treatment progressed was the protein group composed of alpha-smooth muscle actin and gamma-smooth muscle actin. These proteins have an almost identical sequence (99.2% sequence similarity) and are thus highly unlikely to be distinguished from each other by MS/ MS analysis. It is likely that the attributed peptides originate from alpha-smooth muscle actin, as it is known to be expressed by periodontal ligament fibroblasts 42 and was detected in patients with maintenance-phase chronic periodontitis. 12 Alpha-smooth muscle actin enables contraction in mesenchymal stem cells and in their connective tissue progeny, 43 and can upregulate fibroblast contractility in wound healing, 44 while collagen gel contraction is dependent on the expression of this molecule. 45 Most interestingly, alpha-smooth muscle actin has been shown to be a marker for a fibroblast subtype that can rapidly remodel the extracellular matrix. 45 The MILP model only utilized endpoint data and, with m = 5, selected the 4 temporal biomarker candidates described above as well as the glycolytic enzyme triosephosphate isomerase. The model assigned triosephosphate isomerase as an indicator of health, and the enzyme was observed in 80% of patients at week 13. Triosephosphate isomerase was eliminated by the other tests due to the high detection rate (90%) at week 1. Triosephosphate isomerase has been detected in saliva in healthy patients, 46 and was found to be significantly downregulated in diseased periodontal pocket tissues from patients with chronic periodontitis. 47 More research must be done to determine the exact role of host or bacterial triosephosphate isomerase in periodontitis, as existing studies have focused on triosephosphate isomerase and other glycolytic enzymes in oral bacteria, which are associated with adhesion. 48, 49 In conclusion, in this study, albeit the low number of participants and the absence of quantitative data, an untargeted high- 
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